Stephane Bancel, the CEO of vaccine maker Moderna (NASDAQ:MRNA) expects that a second COVID-19 booster might be required this fall as the vaccine’s efficacy declines over the next few months.
“I still believe we’re going to need boosters in the fall of ’22 and forward,” New York Post quoted Bancel as saying on Thursday at a healthcare conference organized by Goldman Sachs.
Bancel added that the company is developing a booster shot targeted at the Omicron variant of the virus, and yet, it is unlikely to be ready in the next two months.
On Monday, Israel, a country at the forefront of the immunization drive against COVID-19 began offering a fourth shot to anyone older than 60. Previously, the officials there had cleared the second booster shot only for people with weaker immune systems.